NCT07191418View on ClinicalTrials.gov

Study-group on Palliative ERCP And RFA-ablation in Metastatic and Inoperable Pancreatic Tumors

NANot yet recruitingINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Pancreatic Cancer Metastatic to Liver
Interventions
DEVICE

Habib™ EndoHPB

This study will hold greater weight compared to previous ones, as it is randomized. It includes 178 patients, exclusively with pancreatic cancer, and is designed as a prospective investigation.

PROCEDURE

ERCP

Endoscopic retrograde cholangiopancreatography (ERCP) as part of clinical routine.

Trial Locations (1)

90185

Department of Surgery, Umeå University Hospital, Umeå

All Listed Sponsors
lead

Roberto Valente

OTHER_GOV